Advances in the imaging and detection of cervical intra-epithelial neoplasia.
Screening for preinvasive disease of the cervix, and detecting and mapping the lesions for treatment, are fundamental to programs for the prevention of cervical cancer. These will become even more important in women vaccinated against humanpapilloma viruses 16 and 18. Biophysical imaging technologies have considerable potential advantages in both screening for and mapping the lesions. This review describes the technologies that seem to have the greatest promise.
Soutter
William Patrick
WP
Honorary Reader in Gynaecological Oncology, Imperial College, 2nd Floor Hammersmith House, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK. p.soutter@imperial.ac.uk
D003952:Diagnostic Imaging / Q000295:instrumentation* / Q000379:methods*; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis*